Michael Notaras

Michael Notaras

Vice President atDecheng CapitalCalifornia

Michael Notaras is a Vice President at Decheng Capital since July 2023. He previously worked in biotechnology equity research at Morgan Stanley and Wolfe Research.

What Michael can write

Writes checks ofNot reported
Comes in atPre-seed, Seed, Series A, Series BLead preference not reported
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Career

  1. Weill Cornell Medical College of Cornell University · NHMRC CJ Martin fellow
  2. Wolfe Research · Associate
  3. Morgan Stanley · Associate
  4. Decheng Capital · Vice President
    Now

Focus

life sciencesbiotechnology

Education

University of Melbourne, Ph.D. in Neuroscience

Also at Decheng Capital

Partners like Michael

At firms with a similar stage, sector and check size.

Alert me when Decheng Capital is active

One email when Michael's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Michael Notaras?

Michael Notaras is a Vice President at Decheng Capital since July 2023. He previously worked in biotechnology equity research at Morgan Stanley and Wolfe Research.

How much does Michael Notaras invest?

Decheng Capital has not reported a check size. It invests at pre-seed, seed, series a, series b.

How do I pitch Michael Notaras?

A warm intro from a founder Decheng Capital backed works best.

What did Michael Notaras do before Decheng Capital?

NHMRC CJ Martin fellow at Weill Cornell Medical College of Cornell University; Associate at Wolfe Research; Associate at Morgan Stanley.

Last updated 2026-10-15. Is this you? Ask for a correction.